Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Dormant
Current status date:
2020-07-23
Original market date: See footnote 1
1994-12-31
Product name:
MICRO PLUS 5 CONCENTRATE
DIN:
02091178
Product Monograph/Veterinary Labelling:
Date:
2021-12-16
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
SANDOZ CANADA INCORPORATED
110 Rue De Lauzon
Boucherville
Quebec
Canada
J4B 1E6
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Intravenous
Number of active ingredient(s):
5
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05XA31 ELECTROLYTES IN COMB WITH OTHER DRUGS
Active ingredient group (AIG) number:See footnote5
0531376001
Active ingredient(s) | Strength |
---|---|
CHROMIUM (CHROMIC CHLORIDE) | 10 MCG / ML |
COPPER (CUPRIC SULFATE) | 1 MG / ML |
MANGANESE (MANGANESE SULFATE) | 0.5 MG / ML |
SELENIUM (SELENIOUS ACID) | 60 MCG / ML |
ZINC (ZINC SULFATE) | 5 MG / ML |